November 19 to 20, the first joint inspection training course for drug registration was held by CFDI in Beijing in 2020.

The course was the first held on-site training of national inspectors by CFDI since the outbreak of COVID-19. The course mainly focused on the training on the new requirements of drug registration inspection after the implementation of the Drug Registration Administration Measures in 2020. More than 230 national drug inspection leaders from all over the country, the director of Drug Registration Dyepartment and inspectors from CFDI attended the training. Zhao Yang, director of the Drug Registration Department of NMPA, delivered a speech on behalf of the Registration Department of NMPA for the opening of the course. Dong Jiangping, deputy director of CFDI, gave the first lesson with the theme of "Ideas and requirements for drug registration inspection after the implementation of the Measures for drug Registration Administration ”.

The new requirements for the implementation of drug registration inspection tasks after the Drug Registration Management Measures issued in 2020 were centered on designing the courses by CFDI including drug registration inspection process, key points of inspection and judgement principle of pharmaceutical development and production, implementation strategy of registration inspection, key points of inspection project and the inspection report writing, etc. Professor Lili from Beijing Friendship Hospital was also invited specially to give a psychological guidance titled “recognition and adjustment of psychological state during the pharmaceutical inspection work”, to help dissolve the pressure of work.

The content of this training course is detailed, the organization is thoughtful, and the participant's unanimous praise was won.

CFDI will carry out the training courses on national inspectors from each province all over the country in a subregional and step-by-step manner.